CervoMed CRVO
NASDAQ CRVO
$2.31 +0.07 (+3.12%)
At close: Oct 23, 2026 · 4:00 PM EDT

CervoMed (CRVO) Cost of Revenue (2011 - 2012)

Updated

CervoMed's Cost of Revenue came in at $235,803 for FY2012, down 89.8% from $2.31 million in FY2011.

Analysis

CervoMed (CRVO) Cost of Revenue (2011 - 2012) Analysis & Trends

  • Per Business Quant, earlier years put Cost of Revenue at $2.31 million in FY2011 (+997.3%) and $210,393 in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 8.10 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 4.29 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.52 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.09 Bn
10 CervoMed 23.66 Mn -62.36 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 850.00
Jun 30, 2012 850.00
Mar 31, 2012 228,502.00
Dec 31, 2011 2.05 Mn
Sep 30, 2011 253,810.00
API Access

CervoMed Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=CRVO&period=max&api_key=YOUR_API_KEY